{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:42:27Z","timestamp":1793817747907,"version":"4.6.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["PID2021\\u2013126811OB-I00-Generacion"],"award-info":[{"award-number":["PID2021\\u2013126811OB-I00-Generacion"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["2020-T1\/BMD-20365"],"award-info":[{"award-number":["2020-T1\/BMD-20365"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["CNS2024"],"award-info":[{"award-number":["CNS2024"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2024\\u2013154308"],"award-info":[{"award-number":["CNS2024\\u2013154308"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semcancer.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:41:07Z","timestamp":1778812867000},"page":"27-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction"],"prefix":"10.1016","volume":"123-124","author":[{"given":"Alicia","family":"Alvarez-Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fernandez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Ortiz-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of Immunometabolism and Implications for Metabolic Health and Disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.3390\/nu6104058","article-title":"The Role for Dietary Omega-3 Fatty Acids Supplementation in Older Adults","volume":"6","author":"Molfino","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2026.05.001_bib3","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/molecules25173935","article-title":"Fatty Acid Synthase: An Emerging Target in Cancer","volume":"25","author":"Fhu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.semcancer.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.it.2014.12.004","article-title":"Targeting T cell metabolism for therapy","volume":"36","author":"O\u2019Sullivan","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.05.001_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ni.2570","article-title":"Sterol regulatory element\u2013binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity","volume":"14","author":"Kidani","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13683","article-title":"Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR\u03b3 directs early activation of T cells","volume":"7","author":"Angela","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MOL.0b013e328352dd03","article-title":"Connecting mTORC1 signaling to SREBP-1 activation","volume":"23","author":"Bakan","year":"2012","journal-title":"Curr. Opin. Lipido"},{"key":"10.1016\/j.semcancer.2026.05.001_bib11","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1016\/j.cub.2009.09.058","article-title":"An Emerging Role of mTOR in Lipid Biosynthesis","volume":"19","author":"Laplante","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cr.2010.13","article-title":"PPARs: diverse regulators in energy metabolism and metabolic diseases","volume":"20","author":"Wang","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1093\/eurheartj\/ehab465","article-title":"Impact of cholesterol on proinflammatory monocyte production by the bone marrow","volume":"42","author":"Stiekema","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.semcancer.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2021.11.048","article-title":"Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications","volume":"79","author":"Vuong","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","article-title":"Fatty acid transport protein 2 reprograms neutrophils in cancer","volume":"569","author":"Veglia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.05.001_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12944-023-01807-1","article-title":"Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy","volume":"22","author":"Qiao","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.semcancer.2026.05.001_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2026.05.001_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.05.001_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12944-023-01876-2","article-title":"Epidemic trends of dyslipidemia in young adults: a real-world study including more than 20,000 samples","volume":"22","author":"Liu","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.semcancer.2026.05.001_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156237","article-title":"Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver","volume":"168","author":"Gruevska","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.semcancer.2026.05.001_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910698","article-title":"Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages","volume":"11","author":"Wu","year":"2019","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.semcancer.2026.05.001_bib25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1158\/0008-5472.CAN-23-3966","article-title":"Estrogen Induces LCAT to Maintain Cholesterol Homeostasis and Suppress Hepatocellular Carcinoma Development","volume":"84","author":"He","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12672-025-02430-5","article-title":"Research progress on cholesterol metabolism and tumor therapy","volume":"16","author":"Chu","year":"2025","journal-title":"Discov. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.05.001_bib27","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.7150\/jca.38598","article-title":"Role of de novo cholesterol synthesis enzymes in cancer","volume":"11","author":"Yang","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2026.05.001_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.molcel.2019.09.008","article-title":"Even Cancer Cells Watch Their Cholesterol!","volume":"76","author":"Riscal","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2026.05.001_bib29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.37349\/etat.2022.00116","article-title":"De novo cholesterol biosynthesis: an additional therapeutic target for the treatment of postmenopausal breast cancer with excessive adipose tissue","author":"Coradini","year":"2022","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.semcancer.2026.05.001_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101055","article-title":"Lipids in the tumor microenvironment: From cancer progression to treatment","volume":"80","author":"Corn","year":"2020","journal-title":"Prog. Lipid Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.05.001_bib32","article-title":"World Health Organization","year":"2023","journal-title":"Cardiovasc Dis."},{"key":"10.1016\/j.semcancer.2026.05.001_bib33","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2026.05.001_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80578-w","article-title":"Association between low-density lipoprotein cholesterol levels and all-cause mortality in patients with coronary artery disease: a real-world analysis using data from an international network","volume":"14","author":"Scudeler","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.05.001_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-020-00963-6","article-title":"Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals","volume":"13","author":"Pedersen","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241311225","article-title":"Low Levels of High-Density Lipoprotein are Associated With Poor Prognosis in Patients With Early Triple-Negative Breast Cancer","volume":"31","author":"Liu","year":"2024","journal-title":"Cancer Control"},{"key":"10.1016\/j.semcancer.2026.05.001_bib37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in Obesity: Mechanisms and Potential Targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2026.05.001_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2796.2010.02325.x","article-title":"The metabolic syndrome: time to get off the merry-go-round?","volume":"269","author":"Reaven","year":"2011","journal-title":"J. Intern Med"},{"key":"10.1016\/j.semcancer.2026.05.001_bib39","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.81034","article-title":"Recent Advances in the Management of Dyslipidemia: A Systematic Review","author":"Jacky Xiao Feng","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.semcancer.2026.05.001_bib40","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.semcancer.2026.05.001_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","article-title":"Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development","volume":"41","author":"O\u2019Sullivan","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.05.001_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-cancerbio-030617-050606","article-title":"Mechanisms of Tumor Cell\u2013Intrinsic Immune Evasion","volume":"2","author":"Spranger","year":"2018","journal-title":"Annu Rev. Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology Meets Immunology: The Cancer-Immunity Cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.05.001_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/lifemeta\/loac038","article-title":"Lipid metabolism in tumor-infiltrating T cells: mechanisms and applications","volume":"1","author":"Ke","year":"2022","journal-title":"Life Metab."},{"key":"10.1016\/j.semcancer.2026.05.001_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.05.001_bib47","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1001\/jama.299.19.2287","article-title":"Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome","volume":"299","author":"Holvoet","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2026.05.001_bib48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/17460875.3.6.637","article-title":"Oxidized LDL and the metabolic syndrome","volume":"3","author":"Holvoet","year":"2008","journal-title":"Future Lipido"},{"key":"10.1016\/j.semcancer.2026.05.001_bib49","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.05.001_bib50","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202202011","article-title":"The low-density lipoprotein receptor\u2013mTORC1 axis coordinates CD8+ T cell activation","volume":"221","author":"Bonacina","year":"2022","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008146","article-title":"HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype","volume":"12","author":"Luo","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.05.001_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","article-title":"Obesity, Inflammation, and Cancer","volume":"11","author":"Deng","year":"2016","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.semcancer.2026.05.001_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib55","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216511","article-title":"PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt\/mTOR-mediated Ca2+ flux","volume":"581","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.05.001_bib57","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41423-023-01011-2","article-title":"Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity","volume":"20","author":"Grajchen","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.05.001_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1186\/s12885-019-6045-y","article-title":"Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period","volume":"19","author":"Niavarani","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.05.001_bib61","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits antitumor responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib63","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood.2020005602","article-title":"Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment","volume":"136","author":"Kobayashi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2026.05.001_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113211","article-title":"Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity","volume":"42","author":"Jiao","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2026.05.001_bib65","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","article-title":"High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice","volume":"158","author":"Qin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2026.05.001_bib66","doi-asserted-by":"crossref","unstructured":"Simple protocol for measuring CD11b+ GR-1+ (Ly6C+\/Ly6G+) myeloid cells from a minimum volume of mouse peripheral blood, 2024, p. 59\u201368. https:\/\/doi.org\/10.1016\/bs.mcb.2024.01.001.","DOI":"10.1016\/bs.mcb.2024.01.001"},{"key":"10.1016\/j.semcancer.2026.05.001_bib67","doi-asserted-by":"crossref","unstructured":"Bruderek K., Schirrmann R., Brandau S. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients, 2021, p. 1\u20137. https:\/\/doi.org\/10.1007\/978-1-0716-1060-2_1.","DOI":"10.1007\/978-1-0716-1060-2_1"},{"key":"10.1016\/j.semcancer.2026.05.001_bib68","article-title":"Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-Derived Suppressor Cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib70","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-Derived Suppressor Cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/onc.2012.113","article-title":"Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model","volume":"32","author":"Alikhani","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2026.05.001_bib73","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/oby.23444","article-title":"Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome","volume":"30","author":"Karra","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/j.semcancer.2026.05.001_bib74","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1038\/s41467-022-33034-0","article-title":"Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6Chi monocytes and differentiation to pro-angiogenic myeloid cells","volume":"13","author":"Tran","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.05.001_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib76","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2026.05.001_bib77","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib78","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.05.001_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semcancer.2026.05.001_bib81","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(08)60241-X","article-title":"Tumour immunity: effector response to tumour and role of the microenvironment","volume":"371","author":"Mantovani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2026.05.001_bib82","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy","volume":"42","author":"Sica","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.05.001_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijo.2023.5599","article-title":"Research progress on the role of tumor-associated macrophages in tumor development and their use as molecular targets (Review)","volume":"64","author":"Lu","year":"2023","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib84","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2020.12097","article-title":"Targeting tumor-associated macrophages in the tumor microenvironment (Review)","volume":"20","author":"Zhou","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2026.05.001_bib85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-Associated Macrophages: From Mechanisms to Therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2026.05.001_bib86","doi-asserted-by":"crossref","unstructured":"Yorek M., Jiang X., Liu S., Hao J., Yu J., Avellino A., et al. FABP4-mediated lipid accumulation and lipolysis in tumor associated macrophages promote breast cancer metastasis 2024. https:\/\/doi.org\/10.1101\/2024.07.02.601733.","DOI":"10.7554\/eLife.101221.1"},{"key":"10.1016\/j.semcancer.2026.05.001_bib87","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib88","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","article-title":"Obesity induces PD-1 on macrophages to suppress anti-tumour immunity","volume":"630","author":"Bader","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.05.001_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115907","article-title":"Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications","volume":"218","author":"Lu","year":"2023","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.semcancer.2026.05.001_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00807","article-title":"Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment","volume":"9","author":"Chimento","year":"2019","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.semcancer.2026.05.001_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103578","article-title":"Dysregulation of cholesterol homeostasis in human lung cancer tissue and tumour-associated macrophages","volume":"72","author":"Hoppst\u00e4dter","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.semcancer.2026.05.001_bib92","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","article-title":"Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression","volume":"29","author":"Goossens","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.05.001_bib93","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/2159-8290.CD-24-0199","article-title":"ROR\u03b3 Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression","volume":"15","author":"Bleve","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.05.001_bib94","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v28.i34.4993","article-title":"Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet","volume":"28","author":"Zheng","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104881","article-title":"Lipid metabolic reprogramming in tumor-associated macrophages: A key driver of functional polarization and tumor immunomodulation","volume":"215","author":"Feng","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib96","doi-asserted-by":"crossref","unstructured":"Macri C., Fancke B., Radford K.J., O\u2019Keeffe M. Monitoring Dendritic Cell Activation and Maturation, 2019, p. 403\u2013418. https:\/\/doi.org\/10.1007\/978-1-4939-9450-2_28.","DOI":"10.1007\/978-1-4939-9450-2_28"},{"key":"10.1016\/j.semcancer.2026.05.001_bib97","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer","volume":"192","author":"Cao","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115574","article-title":"Reprogramming the lipid metabolism of dendritic cells in tumor immunomodulation and immunotherapy","volume":"167","author":"Sun","year":"2023","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.semcancer.2026.05.001_bib99","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/eji.202048944","article-title":"Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells","volume":"51","author":"Almeida","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib100","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170945","article-title":"Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies","volume":"37","author":"Dong","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.semcancer.2026.05.001_bib101","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2026.05.001_bib102","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/jrms.jrms_267_22","article-title":"The tangled web of dyslipidemia and cancer","volume":"27","author":"Neshat","year":"2022","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.semcancer.2026.05.001_bib103","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: New perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.semcancer.2026.05.001_bib104","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jlb.62.6.771","article-title":"Dietary fish oil diminishes the antigen presentation activity of rat dendritic cells","volume":"62","author":"Sanderson","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib105","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.apsb.2022.10.027","article-title":"The impact of lipids on the cancer\u2013immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.semcancer.2026.05.001_bib106","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41467-017-02186-9","article-title":"Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer","volume":"8","author":"Veglia","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.05.001_bib107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-024-02024-0","article-title":"Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy","volume":"23","author":"Wu","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.semcancer.2026.05.001_bib108","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.20061737","article-title":"Dyslipidemia inhibits Toll-like receptor\u2013induced activation of CD8\u03b1-negative dendritic cells and protective Th1 type immunity","volume":"204","author":"Shamshiev","year":"2007","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.semcancer.2026.05.001_bib109","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1194\/jlr.M009449","article-title":"Lipidomics reveals a remarkable diversity of lipids in human plasma","volume":"51","author":"Quehenberger","year":"2010","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib110","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1021\/acs.jproteome.4c00646","article-title":"Recent Developments in Single-Cell Metabolomics by Mass Spectrometry\u2500A Perspective","volume":"24","author":"Petrova","year":"2025","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib111","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/molecules28062712","article-title":"Mass Spectrometry Imaging for Single-Cell or Subcellular Lipidomics: A Review of Recent Advancements and Future Development","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.semcancer.2026.05.001_bib112","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","article-title":"Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.05.001_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100164","article-title":"The foundations and development of lipidomics","volume":"63","author":"Han","year":"2022","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.semcancer.2026.05.001_bib114","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/s12967-025-06542-y","article-title":"Lipidomics reveals biomarkers of the efficacy of first-line ICI therapy combined with chemotherapy in NSCLC","volume":"23","author":"Yu","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.semcancer.2026.05.001_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117350","article-title":"Mass spectrometry-based single-cell lipidomics: Advancements, challenges, and the path forward","volume":"169","author":"Randolph","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.semcancer.2026.05.001_bib116","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00216-019-02241-y","article-title":"Lipidomics from sample preparation to data analysis: a primer","volume":"412","author":"Z\u00fcllig","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.semcancer.2026.05.001_bib117","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1720113115","article-title":"Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth","volume":"115","author":"Pacella","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcancer.2026.05.001_bib118","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cas.15999","article-title":"<scp>SCD1<\/scp> inhibition enhances the effector functions of <scp>CD8<\/scp> + T cells via <scp>ACAT1<\/scp> -dependent reduction of esterified cholesterol","volume":"115","author":"Sugi","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2026.05.001_bib119","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41423-023-01011-2","article-title":"Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity","volume":"20","author":"Grajchen","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41590-018-0292-y","article-title":"Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47\u2212mediated \u2018don\u2019t-eat-me\u2019 signal","volume":"20","author":"Liu","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib121","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.7150\/thno.41388","article-title":"Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.semcancer.2026.05.001_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107923","article-title":"Exploiting the obesity-associated immune microenvironment for cancer therapeutics","volume":"229","author":"Desharnais","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.semcancer.2026.05.001_bib123","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.05.001_bib124","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3390\/cancers15153948","article-title":"Statins in Cancer Prevention and Therapy","volume":"15","author":"Ricco","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2026.05.001_bib125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2020.11.017","article-title":"Effects of caloric restriction on immunosurveillance, microbiota and cancer cell phenotype: Possible implications for cancer treatment","volume":"73","author":"Pistollato","year":"2021","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.05.001_bib126","article-title":"Restricting lipid accumulation in tumor-infiltrating neutrophils mediates caloric restriction-induced anti-cancer effects","author":"Gao","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2026.05.001_bib127","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2016.05.016","article-title":"Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance","volume":"30","author":"Pietrocola","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2026.05.001_bib128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: Molecular Mechanisms and Clinical Applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:45:18Z","timestamp":1788486318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X26000489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":128,"alternative-id":["S1044579X26000489"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.05.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic lipid metabolic alterations and the tumor microenvironment: A hidden driver of immune dysfunction","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}